Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001297077-09-000007
Filing Date
2009-03-17
Accepted
2009-03-17 16:52:33
Documents
10
Period of Report
2009-01-31

Document Format Files

Seq Description Document Type Size
1 cbi10q_13109v94.htm 10-Q 180380
2 EXHIBIT 10.1 cbi10q_13109v94ex10-1.htm EX-10 258538
3 EXHIBIT 31.1 cbi10q_13109ex31-1.htm EX-31 10680
4 EXHIBIT 31.2 cbi10q_13109ex31-2.htm EX-31 10229
5 EXHIBIT 31.3 cbi10q_13109ex31-3.htm EX-31 9337
6 EXHIBIT 32.1 cbi10q_13109ex32-1.htm EX-32 5214
7 cbi10q_13109v94ex10-100.jpg GRAPHIC 60336
8 cbi10q_13109v94ex10-103.jpg GRAPHIC 48365
9 cbi10q_13109v94ex10-101.jpg GRAPHIC 105561
10 cbi10q_13109v94ex10-102.jpg GRAPHIC 91183
  Complete submission text file 0001297077-09-000007.txt   897465
Mailing Address 2200 WILSON BLVD. SUITE 102-316 ARLINGTON VA 22201
Business Address 2200 WILSON BLVD SUITE 102-316 ARLINGTON VA 22201 703-526-0400
CHAMPIONS BIOTECHNOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 000-17263 | Film No.: 09688552
SIC: 2836 Biological Products, (No Diagnostic Substances)